UBS maintains a 'Neutral' on Eli Lilly (NYSE: LLY) price target of $42.00.

Analyst, Marc Goodman, noted the recent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE